Coronavirus Symptoms: 'Razor blade' sore throat: New COVID symptom everyone's talking about, explained in detail
'Nimbus' is on the rise. No, it's not the Harry Potter broom that we are talking about. It's the new COVID-19 variant around the block.
Since early June, reports have emerged of a strikingly painful sore throat associated with the Omicron subvariant NB.1.8.1, unofficially dubbed Nimbus.
Tired of too many ads? go ad free now
The new COVID variant is already causing a surge, and symptoms of the infection are being dubbed as 'Razor blade', implying a severe sore throat that feels like 'razor blades'.
The fresh wave of panic:
The new COVID-19 variant, designated NB.1.8.1 and informally known as 'Nimbus', has been causing a notable increase in cases across Asia and prompting monitoring from the World Health Organization (WHO). This variant is characterized by a particularly severe sore throat symptom described as feeling like 'razor blades', alongside traditional flu-like symptoms such as congestion, fatigue, mild cough, fever, and muscle aches.
Less common symptoms include diarrhea and nausea. The symptoms have been described in dramatic terms like 'Swallowing shattered glass,' 'Like razor blades' in the throat, and a sharp, stabbing pain with every swallow.
Already comprising over 10% of cases in Asia, the variant has also been detected in the United States of America, Canada, and Europe. A preprint study indicates that Nimbus has high immune evasion, suggesting potential for widespread transmission.
However, WHO maintains that the current global risk is low and existing vaccines remain effective in preventing severe illness.
The rise of 'razor blade throat':
In the United States of America, Nimbus now accounts for approximately 37% of sequenced cases as of early June, and about 11% globally by mid-May, as reported by Associated Press. Although up to 70% of COVID infections include sore throat, according to UCSF, and severe throat pain appears with multiple variants, patients infected with the Nimbus variant have reported an intense sore throat, often described as feeling like swallowing shards of glass, reports have said citing doctors.
Tired of too many ads? go ad free now
The intensity of the symptom might vary – it can be mild for some, but excruciating for others – impacting their ability to talk, swallow, eat, or stay hydrated. However, the sharp pain in the throat can be so severe that it hinders speaking, eating, or staying hydrated. While sore throat has always varied in intensity among COVID-19 patients, the Nimbus variant has brought this symptom to the forefront due to its severity.
Health authorities are still evaluating how common and unique this intense sore throat is with Nimbus versus earlier strains.
'Feels like broken glasses… razor blades'
Patients suffering from the infection of the Nimbus strain have been reporting online about their experience with the 'razor blade' symptom, saying, 'Feels like broken glasses… razor blades.'
For those experiencing the painful throat associated with the Nimbus variant, several remedies may provide relief:
Over-the-counter medications:
Pain relievers such as paracetamol (acetaminophen) or ibuprofen can help alleviate throat pain and reduce inflammation.
Warm saltwater gargle:
Gargling with warm saltwater can soothe the throat and may help reduce viral load.
Throat lozenges and sprays:
Products containing menthol or benzocaine can numb the throat and provide temporary relief.
Hydration:
drinking warm liquids like herbal teas or broths can keep the throat moist and alleviate discomfort.
Humidifiers:
Using a humidifier can add moisture to the air, preventing the throat from becoming dry and irritated.
Apart from these convenient remedies, it's essential to monitor symptoms and consult a healthcare provider if throat pain persists or worsens.
While the Nimbus variant presents a new challenge with its painful throat symptoms, understanding the condition and taking appropriate measures can help manage and alleviate discomfort. Although most cases of the Nimbus variant result in mild illness, certain signs indicate the need for medical evaluation. If the throat pain or other symptoms do not improve or worsen over time, or you experience shortness of breath or chest tightness, coupled with a fever that remains above 100°F (37.8°C) for several days – you must consult with a professional healthcare provider.
Individuals with underlying health conditions, the elderly, or those who are pregnant should seek medical advice promptly if symptoms arise.
Watch! Former AIIMS Chief Dr. Randeep Guleria reveals shocking truth about COVID-19 JN.1 variant
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
an hour ago
- Time of India
Rise in Cov cases with mild symptoms, outbreak nears plateau: Docs
1 2 3 Kolkata: The number of Covid patients with mild symptoms shot up in Kolkata over the last week, indicating that the outbreak is about to reach a plateau and taper off with a subsequent dip, say experts. Several hospitals have already seen a drop in patients testing positive at their outpatient departments (OPD), while those testing positive now have very mild symptoms. Although very few of these patients were admitted, the rise in transmission would help to halt the spread, doctors said. "Once half the city's population gets the infection, numbers will start dipping. We saw a spurt last week, while the numbers have started dipping over the last three to four days. Most patients have very mild symptoms — low fever and cough — with a few getting respiratory tract infections that are manageable at home. The elderly with comorbidities continue to be admitted, but now their number should start dropping," said Manipal Hospital Dhakuria infectious diseases physician Sayan Chakrabarty. Peerless Hospital has seen a drop in number of patients for the first time since June 1. The hospital tested 65 patients between June 1 and 15, of whom 35 were positive. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Giao dịch CFD với công nghệ và tốc độ tốt hơn IC Markets Đăng ký Undo "While some, including kids, needed admission, most had mild symptoms and were treated at the OPD. The positivity rate was above 50% till Friday when just one tested positive. None tested positive on Saturday and Sunday," said Peerless chief microbiologist Bhaskar Narayan Chaudhury. CMRI Hospital has nine patients admitted, down from an average of 14 till last week. The current strain is very transmissible but triggers mild symptoms that led to a quick spread, said CMRI pulmonology director Raja Dhar. "Symptoms have been restricted to mild fever and cough for the vast majority, and they, of course, don't require admission. We have seen a proliferation of young patients with symptoms, which indicates that the spread has hastened and a plateau is imminent," added Dhar. He added that the hospital admitted just two patients in last four days and plans to start reducing the number of isolation beds by next week from the current 14 to six if the trend persists. Even though several patients are admitted at Fortis Hospital Anandapur, many more have been treated at the OPD and did not require admission, said Fortis pulmonologist Sushmita Roychowdhury. "Severe cases are still happening but have slid. Many more have mild symptoms now, which is an indication that we are finally heading towards a plateau," said Roychowdhury. Manipal Hospitals have multiple patients across its four units, including four at Dhakuria. "Barring a couple, the rest have severe lung or cardiac ailments or have hypertension and diabetes. They tested Covid positive on admission, but their symptoms are largely mild and manageable," added Chakrabarty. While the Dhakuria unit now has 10 Covid beds, including five at the ICU, the Mukundapur unit has five isolation cabins, and the Salt Lake unit has another five. Medica has isolation cabins with separate entry and exit points. Sources said both Medica and Mukundapur have elderly patients with comorbidities who tested positive on admission.
Indian Express
an hour ago
- Indian Express
A new Covid variant Nimbus aka ‘razor blade throat' is on the rise. All you need to know
India is witnessing a fresh uptick in COVID-19 cases, with over 7,000 active infections and more than 70 deaths reported recently. While SARS-CoV-2 has become a recurring seasonal presence, much like influenza, a new variant, NB.1.8.1, nicknamed 'Nimbus', is drawing global attention for its unusually painful symptom: a sore throat that some are describing as feeling like 'razor blades.' Indian doctors confirm that a few patients have reported this distressing feature. Where has the Nimbus spread? The NB.1.8.1 variant has spread rapidly across China and Hong Kong, and cases have now been detected in several US states, including California, Washington, Virginia, and New York, according to an Associated Press report. Australia has also recorded cases. In the UK, 13 cases were confirmed in June, accompanied by a nearly 10 per cent rise in hospitalisations, The Independent reported. The variant and symptoms have also been detected in India. By mid-May, NB.1.8.1 accounted for nearly 11 per cent of all sequenced COVID samples globally, signaling a rapid rise in circulation. What are the symptoms? The most reported and defining symptom of the Nimbus variant is a severely painful sore throat. Other symptoms include fever, chills, cough, shortness of breath, and loss of taste or smell. However, the World Health Organization (WHO) has stated that the variant does not appear to cause more severe illness than previous strains and is currently considered low risk. What has WHO said? The WHO has classified NB.1.8.1 as a 'variant under monitoring,' indicating that while it is spreading, it doesn't yet pose a major threat. The organisation has also confirmed that current COVID-19 vaccines remain effective in preventing severe outcomes linked to the variant. 'The WHO assesses the additional risk to the global public as currently low, and existing COVID-19 vaccines are considered effective in preventing severe disease,' Dr Naveed Asif, a general practitioner at The London General Practice, told The Independent. Which vaccines offer protection? Vaccines approved by the US FDA – Moderna, Pfizer-BioNTech, and Novavax – are expected to be effective against NB.1.8.1, especially because it belongs to the Omicron JN.1 lineage. An article by New York-Presbyterian/Columbia University Irving Medical Center stresses the importance of staying up-to-date with boosters. Those with underlying health conditions like diabetes, heart disease, or hypertension should take extra precautions, as their immune response may not be as robust. Why Nimbus spreads faster Scientists believe NB.1.8.1 may spread more efficiently due to stronger binding with human cells. A Gavi report noted that the variant binds tightly to the ACE2 receptor, which SARS-CoV-2 uses to enter the body. 'Using lab-based models, researchers found NB.1.8.1 had the strongest binding affinity to the human ACE2 receptor of several variants tested,' said virologist Lara Herrero from Griffith University in The Conversation, 'suggesting it may infect cells more efficiently than earlier strains.' Dr Chun Tang, a general practitioner at UK-based Pall Mall Medical, added that while the variant isn't drastically different from Omicron, 'some tweaks to its spike protein' may make it more transmissible or help it evade immunity. 'What sets NB.1.8.1 apart is how quickly it spreads,' said Dr Magdalena Sobieszczyk, Chief of Infectious Diseases at New York-Presbyterian/Columbia. 'It has a genetic advantage: mutations that make it easy for it to bind to receptors on human cells.' Prevention is key Precautions remain largely the same. Mask up in crowded places, cover your mouth while coughing or sneezing, wash and sanitise your hands regularly, and avoid stepping out if unwell. Ventilated spaces remain safer, especially during spikes in transmission. No, 'Nimbus' isn't a Harry Potter reference While some may associate 'Nimbus' with the magical broomstick from 'Harry Potter' or characters from 'Rick and Morty', the nickname actually refers to a type of cloud. Professor T Ryan Gregory of the University of Guelph in Canada explained to Gavi' that naming conventions like 'Nimbus' (NB.1.8.1) and 'Stratus' (XFG) help make emerging variants easier to track and communicate to the public.
&w=3840&q=100)
Business Standard
3 hours ago
- Business Standard
Younger population seeing high rates of infection amid Covid surge: Experts
As India confronts a fresh surge in Covid-19 cases, doctors suggest that the virus is disproportionately affecting younger age groups, with the 18-45 age bracket bearing the brunt of the infection. According to data available on the Union health ministry's Covid dashboard, India has 5,976 active cases from 29 states and Union Territories (UTs) as of June 19. Of these, Kerala has the highest caseload at 1,309, followed by Gujarat and Delhi at 1,046 and 632 cases, respectively. While the government does not give an age- or gender-wise breakup of cases, doctors are seeing a noticeable increase in Covid-19 cases among young adults, specifically those aged between 18 and 45. Tushar Tayal, consultant-internal medicine at CK Birla Hospital, Gurugram, said that on average, 10-12 patients per day were coming to him with flu-like symptoms and a small but steady percentage of them were testing positive for Covid-19. 'This may be indicative of a silent surge that is frequently overlooked because other viral infections overlap and (there's) an overall reduction in the rate of testing,' he added. Aakashneel Bhattacharya, consultant-infectious diseases at Paras Heath in Gurugram said that 80-85 per cent of Covid patients coming to him fell into the same 18-45 age bracket. Young adults previously considered to be at relatively low risk of severe illness are now showing heightened susceptibility, particularly those with a poor follow-up history of vaccination or waning immunity. Divya K S, an infectious disease specialist at Apollo Hospitals in Sheshadripuram, Bengaluru, said that waning immunity over the years, in addition to the emergence of immune-evading strains, made the younger population more vulnerable. Tayal said that in the 18-25 age group, most came with high-grade fever, throat pain, tiredness, body pain, and sometimes gastrointestinal symptoms of nausea or diarrhoea. Some also complained of a dry cough lasting for days and mild difficulty in breathing. In individuals over 30, symptoms persisted longer, and there were more instances of prolonged fatigue or post-viral cough, he added. Commenting on the reasons, Bhattacharya said younger people were at high risk of contracting the infection as they were the ones who mostly went out and mixed up with other people in the community. 'Till now, we are not seeing patients developing serious pneumonia or having low oxygen saturation. While a few patients may have had minor pneumonia, they are not requiring oxygen,' he added. Tayal, however, said that although most cases of Covid in younger patients were not serious, there should be caution against complacency. 'Reinfections are being observed even in persons who have been vaccinated or infected before, pointing to changing viral strains,' he added. Another reason was that many younger patients were delaying getting tested, assuming the infection to be a seasonal flu or viral fever, he further said. Nidhin Mohan, consultant-internal medicine, Narayana Health City, Bengaluru, said that there was a spike among individuals who had recently travelled, especially for work or weddings, without taking adequate precautions. 'Infectious strains that spread faster within a group that is in close contact with each other can result in more case numbers among younger populations, who tend to be at the centre of workplace and social interactions,' said Deepesh G Aggarwal, consultant physician and head of department for critical care medicine at Saifee Hospital, Mumbai.
